4.0 Article

Hepatoprotective effect of Ficus religiosa latex on cisplatin induced liver injury in Wistar rats

Publisher

SOC BRASILEIRA FARMACOGNOSIA
DOI: 10.1016/J.BJP.2015.03.012

Keywords

Hepatoprotective; Ficus religiosa latex; Cisplatin; Liver injury

Ask authors/readers for more resources

Ficus religiosa L., Moraceae, is widely planted in the tropics. The chemical constituents of F. religiosa include tannin, saponin gluanol acetate, p-sitosterol, leucoanthocyanidin, and leucoanthocyanin. These are used for the treatment of pain, inflammation, impotence, menstrual disturbances, and urine related problems, and as uterine tonic. The present study aimed to evaluate hepatoprotective effects of F. religiosa latex on cisplatin induced liver injury in Wistar rats. In experimental protocol contained five groups of rats (n=6). In which, group I (control) was administered acacia (2%, w/v) of 5 ml/kg throughout the experiment for 16 days. The group II (cisplatin treated) was administered single dose of cisplatin (7.5 mg/kg i.p.) on 1st day. Group III (extract control) was administered 300 mg/kg p.o. of extract for 1st to 10th day. Group IV (Protective) was administered extract (300 mg/kg p.o.) of F. religiosa latex for 1st to 10th day and administered single dose of cisplatin (7.5 mg/kg i.p.) on 11th day and group V (Curative) received single dose of cisplatin (7.5 mg/kg i.p.) on day 1st, and administered extract (300 mg/kg p.o.) from 7th to 16th days. On the 6th day in cisplatin treated, 10th day in extract control and 16th day in control, protective and curative, blood withdrawn from retro-orbital sinus of rats for biochemical estimation for serum and dissected out the livers for estimation of antioxidant enzymes and histopathological works. The cisplatin-treated group 2 showed a significant increase in serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and hepatocytes cells degeneration inflammatory infiltrate and necrosis it's were significantly (**p <0.01) alleviates by protective groups. (C) 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Hepatoprotective effect of Ficus religiosa latex on cisplatin induced liver injury in Wistar rats

Yogesh C. Yadav

REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY (2015)

Article Pharmacology & Pharmacy

Antiurolithiatic effect of lithocare against ethylene glycol-induced urolithiasis in Wistar rats

Sumaiya I. Lulat, Yogesh Chand Yadav, R. Balaraman, Rajesh Maheshwari

INDIAN JOURNAL OF PHARMACOLOGY (2016)

Article Plant Sciences

Nephroprotective and curative effects of Ficus religiosa latex extract against cisplatin-induced acute renal failure

Yogesh Chand Yadav, D. N. Srivastava

PHARMACEUTICAL BIOLOGY (2013)

Article Chemistry, Medicinal

Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect

Yogesh Chand Yadav, Satyanarayan Pattnaik, Kalpana Swain

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)

Review Biotechnology & Applied Microbiology

An Update on Assessment, Therapeutic Management, and Patents on Insomnia

Amit Porwal, Yogesh Chand Yadav, Kamla Pathak, Ramakant Yadav

Summary: Insomnia is a common condition that significantly impacts function and quality of life, but the treatment rate remains low, highlighting the need for continued development of effective treatments. Various critical viewpoints and treatment options, including both pharmacological and nonpharmacological therapies, need to be considered for the treatment of insomnia.

BIOMED RESEARCH INTERNATIONAL (2021)

Review Pharmacology & Pharmacy

Review on Preclinical and Clinical Evidence of Food (Beverages, Fruits and Vegetables) and Drug Interactions: Mechanism and Safety

Yogesh C. Yadav, Kamla Pathak, Devender Pathak

CURRENT DRUG THERAPY (2020)

No Data Available